pevonedistat
intravenous NEDD8-activating enzyme inhibitor Ph. III candidate for oncology from HTS and optimization Drug Metab. Dispos., July, 2022 Takeda, Lexington, MA
Molecules of the Month - May 2022
Molecules of the Month
- pevonedistat
- compound 20
- NVP-CLR457
- TXA6101
- RLX-33
- INCB13739
- compound 4e
- MAGLi 432
- sudapyridine (WX-081)
- dorzagliatin